Zydus Lifesciences Ltd’s share price surged 2% after the USFDA approved two of its products, boosting investor confidence and solidifying the company’s position in the global pharmaceutical industry.

Zydus Lifesciences Limited has acquired a majority stake in Amplitude Surgical SA, marking a strategic expansion into surgical technology and potentially opening new revenue streams for the company.